Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Healthy Volunteer
This research aims to better understand outcomes of quitting e-cigarettes in adults who also use cannabis. It focuses on how cannabis and tobacco interact during quitting attempts using varenicline, a medication approved for cigarette cessation but not for e-cigarette cessation. The study targets adults aged 18 to 40 who use both e-cigarettes and cannabis, regardless of their interest in quitting cannabis. The trial is conducted at three sites in South Carolina. Participants receive a 12-week treatment with varenicline following a standard dose schedule starting from 0.5 mg once daily and increasing to 1.0 mg twice daily, maintained for 11 weeks. Alongside medication, participants receive psychosocial counseling and financial incentives each week based on verified abstinence from e-cigarettes using urinary cotinine tests. This approach combines medication, behavioral support, and incentives. During the study, participants will attend weekly visits for assessments including urine tests to confirm tobacco abstinence and cannabis use. Researchers will track changes in cannabis use during the treatment and evaluate the impact of cannabis use severity on quitting success. The main outcome measured is 7-day tobacco abstinence at the end of 12 weeks. The total study duration per participant is 12 weeks, with monitoring throughout this period.
Actively Recruiting
Healthy Volunteer
This research investigates if switching completely to e-cigarettes nicotine vapes helps people who smoke and are in treatment for substance use disorder SUD quit smoking, compared to using FDA-approved nicotine replacement therapy NRT like patches and lozenges. Tobacco use rates remain high among those with SUD, impacting their treatment outcomes and health. The study aims to assess if e-cigarettes can be a feasible and acceptable alternative for quitting tobacco in this population. Participants are randomly assigned to one of two groups one group receives combination nicotine replacement therapy with patches and lozenges for 12 weeks, while the other group receives a study-provided e-cigarette product for 12 weeks with instructions to switch completely. Both groups also receive brief weekly counseling to support their quit or switch attempt. The study includes 14 weekly visits and two follow-up visits over 6 months, with daily diary entries completed on phones during the first 12 weeks. During the study, participants undergo breath and urine tests to confirm smoking status and provide data on tobacco abstinence. Researchers measure smoking abstinence at 12 weeks, intervention acceptability, and substance use outcomes through urine drug screens. Study visits may be in-person or virtual. The total participation lasts 6 months, allowing close monitoring and support during the quit or switch process.